Physostigmine increases the dose of propofol required to induce anaesthesia

Argyro Fassoulaki, Konstantinos D. Sarantopoulos, Ch Derveniotis

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Purpose: This prospective, randomized, double-blind study was performed to determine the effect of administration of physostigmine on the dose of propofol required to produce loss of consciousness. Methods: Forty female unpremedicated patients were assigned in a random blind design to receive either 2 mg physostigmine or equal volume of normal saline iv, five minutes before induction of anaesthesia with propofol. All patients received general anaesthesia for breast surgery. Propofol was infused at a constant rate of 200 ml · hr-1 while patients were breathing oxygen 100% via a face mask. In each patient the dose of propofol required to produce loss of the ability to grasp a 20 ml synnge was recorded as the end-point of loss of consciousness. At this point the protocol was terminated and, after intubation of the trachea, anaesthesia was maintained with a nitrous oxide-isoflurane or sevoflurane mixture in oxygen, increments of an opioid and a muscle relaxant. Doses of anaesthetic drugs and duration of anaesthesia vaned and depended on the type of breast surgery, determined by frozen section. Results: The mean ± SD dose of propofol required to produce loss of consciousness was 2.4 ± 0.6 mg · kg-1 and 2.0 ± 0.4 mg · kg-1 in the physostigmine and in the normal saline groups respectively (P = 0.014). Conclusion: Physostigmine pretreatment increases the dose of propofol required to produce loss of consciousness.

Original languageEnglish
Pages (from-to)1148-1151
Number of pages4
JournalCanadian Journal of Anaesthesia
Volume44
Issue number11
DOIs
StatePublished - Nov 1 1997
Externally publishedYes

Fingerprint

Physostigmine
Propofol
Unconsciousness
Anesthesia
Breast
Oxygen
Isoflurane
Nitrous Oxide
Frozen Sections
Masks
Trachea
Double-Blind Method
Intubation
General Anesthesia
Opioid Analgesics
Anesthetics
Respiration
Muscles

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Physostigmine increases the dose of propofol required to induce anaesthesia. / Fassoulaki, Argyro; Sarantopoulos, Konstantinos D.; Derveniotis, Ch.

In: Canadian Journal of Anaesthesia, Vol. 44, No. 11, 01.11.1997, p. 1148-1151.

Research output: Contribution to journalArticle

@article{192fec6a331743fb954b4c3112ad39e1,
title = "Physostigmine increases the dose of propofol required to induce anaesthesia",
abstract = "Purpose: This prospective, randomized, double-blind study was performed to determine the effect of administration of physostigmine on the dose of propofol required to produce loss of consciousness. Methods: Forty female unpremedicated patients were assigned in a random blind design to receive either 2 mg physostigmine or equal volume of normal saline iv, five minutes before induction of anaesthesia with propofol. All patients received general anaesthesia for breast surgery. Propofol was infused at a constant rate of 200 ml · hr-1 while patients were breathing oxygen 100{\%} via a face mask. In each patient the dose of propofol required to produce loss of the ability to grasp a 20 ml synnge was recorded as the end-point of loss of consciousness. At this point the protocol was terminated and, after intubation of the trachea, anaesthesia was maintained with a nitrous oxide-isoflurane or sevoflurane mixture in oxygen, increments of an opioid and a muscle relaxant. Doses of anaesthetic drugs and duration of anaesthesia vaned and depended on the type of breast surgery, determined by frozen section. Results: The mean ± SD dose of propofol required to produce loss of consciousness was 2.4 ± 0.6 mg · kg-1 and 2.0 ± 0.4 mg · kg-1 in the physostigmine and in the normal saline groups respectively (P = 0.014). Conclusion: Physostigmine pretreatment increases the dose of propofol required to produce loss of consciousness.",
author = "Argyro Fassoulaki and Sarantopoulos, {Konstantinos D.} and Ch Derveniotis",
year = "1997",
month = "11",
day = "1",
doi = "10.1007/BF03013335",
language = "English",
volume = "44",
pages = "1148--1151",
journal = "Canadian journal of anaesthesia = Journal canadien d'anesth{\'e}sie",
issn = "0008-2856",
publisher = "Canadian Anaesthetists Society",
number = "11",

}

TY - JOUR

T1 - Physostigmine increases the dose of propofol required to induce anaesthesia

AU - Fassoulaki, Argyro

AU - Sarantopoulos, Konstantinos D.

AU - Derveniotis, Ch

PY - 1997/11/1

Y1 - 1997/11/1

N2 - Purpose: This prospective, randomized, double-blind study was performed to determine the effect of administration of physostigmine on the dose of propofol required to produce loss of consciousness. Methods: Forty female unpremedicated patients were assigned in a random blind design to receive either 2 mg physostigmine or equal volume of normal saline iv, five minutes before induction of anaesthesia with propofol. All patients received general anaesthesia for breast surgery. Propofol was infused at a constant rate of 200 ml · hr-1 while patients were breathing oxygen 100% via a face mask. In each patient the dose of propofol required to produce loss of the ability to grasp a 20 ml synnge was recorded as the end-point of loss of consciousness. At this point the protocol was terminated and, after intubation of the trachea, anaesthesia was maintained with a nitrous oxide-isoflurane or sevoflurane mixture in oxygen, increments of an opioid and a muscle relaxant. Doses of anaesthetic drugs and duration of anaesthesia vaned and depended on the type of breast surgery, determined by frozen section. Results: The mean ± SD dose of propofol required to produce loss of consciousness was 2.4 ± 0.6 mg · kg-1 and 2.0 ± 0.4 mg · kg-1 in the physostigmine and in the normal saline groups respectively (P = 0.014). Conclusion: Physostigmine pretreatment increases the dose of propofol required to produce loss of consciousness.

AB - Purpose: This prospective, randomized, double-blind study was performed to determine the effect of administration of physostigmine on the dose of propofol required to produce loss of consciousness. Methods: Forty female unpremedicated patients were assigned in a random blind design to receive either 2 mg physostigmine or equal volume of normal saline iv, five minutes before induction of anaesthesia with propofol. All patients received general anaesthesia for breast surgery. Propofol was infused at a constant rate of 200 ml · hr-1 while patients were breathing oxygen 100% via a face mask. In each patient the dose of propofol required to produce loss of the ability to grasp a 20 ml synnge was recorded as the end-point of loss of consciousness. At this point the protocol was terminated and, after intubation of the trachea, anaesthesia was maintained with a nitrous oxide-isoflurane or sevoflurane mixture in oxygen, increments of an opioid and a muscle relaxant. Doses of anaesthetic drugs and duration of anaesthesia vaned and depended on the type of breast surgery, determined by frozen section. Results: The mean ± SD dose of propofol required to produce loss of consciousness was 2.4 ± 0.6 mg · kg-1 and 2.0 ± 0.4 mg · kg-1 in the physostigmine and in the normal saline groups respectively (P = 0.014). Conclusion: Physostigmine pretreatment increases the dose of propofol required to produce loss of consciousness.

UR - http://www.scopus.com/inward/record.url?scp=0031450338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031450338&partnerID=8YFLogxK

U2 - 10.1007/BF03013335

DO - 10.1007/BF03013335

M3 - Article

C2 - 9398952

AN - SCOPUS:0031450338

VL - 44

SP - 1148

EP - 1151

JO - Canadian journal of anaesthesia = Journal canadien d'anesthésie

JF - Canadian journal of anaesthesia = Journal canadien d'anesthésie

SN - 0008-2856

IS - 11

ER -